Q1 2024 Earnings Call Transcript May 2, 2024 Zoetis Inc. beats earnings expectations. Reported EPS is $1.38, expectations ...

Apoquel is a great option for many dogs with allergic skin conditions. It works quickly to relieve symptoms and has a low risk of side effects. However, Apoquel can be expensive for some pet ...

Zoetis (ZTS) reports better-than-expected first-quarter results, wherein both earnings and revenues beat estimates. Shares ...

Sales of companion animal products increased by 25%, driven by growth in key franchises including Simparica Trio, flea, tick ...

Zoetis' (ZTS) higher companion animal product sales are expected to have driven revenues in the first quarter of 2024 in both ...

Explore how Zoetis Inc (ZTS) achieved significant operational growth and navigated market complexities in the first quarter of 2024.

Navann Ty Dietschi; Pharmaceuticals and Medtech Analyst; BNP Paribas Exane, Research Division ...

So is that the correct way to think about it? And then on derm, the company decided to start selling Apoquel Chewable through distribution. Could you maybe just talk about the factors that led to ...

These included OA pain products, Librela for dogs and Solensia for cats, dermatology products like Apoquel and Cytopoint, as well as Zoetis’ parasiticide products, such as Simparica and the ...

Growth in the quarter was driven by the company's OA pain products, Librela for dogs and Solensia for cats, as well as its key dermatology products, Apoquel and Cytopoint. Also contributing to ...

Repeat. It's hard to watch your pup experience this kind of discomfort. Enter Apoquel for dogs, a veterinary drug that can relieve itching caused by allergies. Like most drugs, Apoquel has some side ...

Apoquel for dogs is a valuable treatment option for pups suffering from atopic dermatitis, as well as some cases of flea allergic dermatitis. It is one of several medications that a vet may reach for ...